Possible involvement of microRNAs in vascular damage in experimental chronic kidney disease

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1842, Issue 1, 2014, Pages 88-98

  Taïbi, Fatiha ^a   Metzinger Le Meuth, Valérie ^a,b   M'Baya Moutoula, Eléonore ^a   Djelouat, Mohamed seif el Islam ^a   Louvet, Loïc ^a   Bugnicourt, Jean Marc ^a,c   Poirot, Sabrina ^a   Bengrine, Abderrahmane ^a   Chillon, Jean Marc ^a   Massy, Ziad A ^a,d   Metzinger, Laurent ^a,c  

^a UNIVERSITÉ DE PICARDIE JULES VERNE   (France)

^b UNIVERSITÉ PARIS 13   (France)

^c AMIENS UNIVERSITY HOSPITAL   (France)

^d LABORATOIRE DES SCIENCES DU CLIMAT ET DE L ENVIRONNEMENT   (France)

Author keywords

Atherosclerosis; Endothelium; Kidney disease; MicroRNA; Smooth muscle

Indexed keywords

APOLIPOPROTEIN E; GLUCOSE TRANSPORTER 4; MICRORNA; MICRORNA 126; MICRORNA 143; MICRORNA 145; MICRORNA 221; MICRORNA 222; MICRORNA 223; MYOCARDIN; NUCLEAR FACTOR I; PLACEBO; SEVELAMER; STROMAL CELL DERIVED FACTOR 1; VASCULAR CELL ADHESION MOLECULE 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; ATHEROSCLEROSIS; BLOOD VESSEL INJURY; CELL FUNCTION; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; DISEASE COURSE; DOWN REGULATION; FEMALE; GENE EXPRESSION; KNOCKOUT MOUSE; MOUSE; NONHUMAN; PHOSPHATE BLOOD LEVEL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN TARGETING; SMOOTH MUSCLE FIBER; TREATMENT RESPONSE; UPREGULATION; WILD TYPE;

APO-E KO; APOLIPOPROTEIN-E KNOCK-OUT; ATHEROSCLEROSIS; CHOL; CHOLESTEROL; CHRONIC KIDNEY DISEASE; CKD; ENDOTHELIUM; GLUCOSE TRANSPORTER TYPE 4; GLUT-4; KIDNEY DISEASE; MICRORNA; MIRNA; MYO; MYOCARDIN; NFI-A; NUCLEAR FACTOR I-A; SDF-1; SMOOTH MUSCLE; STROMAL CELL-DERIVED FACTOR-1; TG; TRYGLYCERIDE; VASCULAR CELL ADHESION MOLECULE-1; VASCULAR SMOOTH MUSCLE CELL; VCAM-1; VSMC; WILD-TYPE; WT;

ANIMALS; AORTA; APOLIPOPROTEINS E; ATHEROSCLEROSIS; CHEMOKINE CXCL12; FEMALE; GENE EXPRESSION REGULATION; GLUCOSE TRANSPORTER TYPE 4; MICE; MICE, KNOCKOUT; MICRORNAS; NFI TRANSCRIPTION FACTORS; NUCLEAR PROTEINS; POLYAMINES; RENAL INSUFFICIENCY, CHRONIC; TRANS-ACTIVATORS; VASCULAR CELL ADHESION MOLECULE-1;

EID: 84887806429     PISSN: 09254439     EISSN: 1879260X     Source Type: Journal    
DOI: 10.1016/j.bbadis.2013.10.005     Document Type: Article

References (41)

1. Massy Z.A., Ivanovski O., Nguyen-Khoa T., Angulo J., Szumilak D., Mothu N., Phan O., Daudon M., Lacour B., Drueke T.B., Muntzel M.S. Uremia accelerates both atherosclerosis and arterial calcification in apolipoprotein E knockout mice. J. Am. Soc. Nephrol. 2005, 16:109-116.
2. Giachelli C.M. The emerging role of phosphate in vascular calcification. Kidney Int. 2009, 75:890-897.
3. Griffiths-Jones S. miRBase: microRNA sequences and annotation. Curr. Protoc. Bioinformatics 2006, D152-D157. (Chapter 12 Unit 12 19).
4. van Rooij E. The art of microRNA research. Circ. Res. 2009, 108:219-234.
5. Wang K., Zhang S., Marzolf B., Troisch P., Brightman A., Hu Z., Hood L.E., Galas D.J. Circulating microRNAs, potential biomarkers for drug-induced liver injury. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:4402-4407.
6. Goettsch C., Hutcheson J.D., Aikawa E. MicroRNA in cardiovascular calcification: focus on targets and extracellular vesicle delivery mechanisms. Circ. Res. 2012, 112:1073-1084.
7. Rangrez A.Y., Massy Z.A., Metzinger-Le Meuth V., Metzinger L. miR-143 and miR-145: molecular keys to switch the phenotype of vascular smooth muscle cells. Circ. Cardiovasc. Genet. 2011, 4:197-205.
8. Wang S., Aurora A.B., Johnson B.A., Qi X., McAnally J., Hill J.A., Richardson J.A., Bassel-Duby R., Olson E.N. The endothelial-specific microRNA miR-126 governs vascular integrity and angiogenesis. Dev. Cell 2008, 15:261-271.
9. Bugnicourt J.M., Da Silveira C., Bengrine A., Godefroy O., Baumbach G., Sevestre H., Bode-Boeger S.M., Kielstein J.T., Massy Z.A., Chillon J.M. Chronic renal failure alters endothelial function in cerebral circulation in mice. Am. J. Physiol. Heart Circ. Physiol. 2011, 301:H1143-H1152.
10. Maizel J., Six I., Slama M., Tribouilloy C., Sevestre H., Poirot S., Giummelly P., Atkinson J., Choukroun G., Andrejak M., Kamel S., Maziere J.C., Massy Z.A. Mechanisms of aortic and cardiac dysfunction in uremic mice with aortic calcification. Circulation 2009, 119:306-313.
11. Harris T.A., Yamakuchi M., Ferlito M., Mendell J.T., Lowenstein C.J. MicroRNA-126 regulates endothelial expression of vascular cell adhesion molecule 1. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:1516-1521.
12. Asgeirsdottir S.A., van Solingen C., Kurniati N.F., Zwiers P.J., Heeringa P., van Meurs M., Satchell S.C., Saleem M.A., Mathieson P.W., Banas B., Kamps J.A., Rabelink T.J., van Zonneveld A.J., Molema G. MicroRNA-126 contributes to renal microvascular heterogeneity of VCAM-1 protein expression in acute inflammation. Am. J. Physiol. Renal. Physiol. 2012, 302:F1630-F1639.
13. Zernecke A., Bidzhekov K., Noels H., Shagdarsuren E., Gan L., Denecke B., Hristov M., Koppel T., Jahantigh M.N., Lutgens E., Wang S., Olson E.N., Schober A., Weber C. Delivery of microRNA-126 by apoptotic bodies induces CXCL12-dependent vascular protection. Sci. Signal. 2009, 2:ra81.
14. Elia L., Quintavalle M., Zhang J., Contu R., Cossu L., Latronico M.V., Peterson K.L., Indolfi C., Catalucci D., Chen J., Courtneidge S.A., Condorelli G. The knockout of miR-143 and -145 alters smooth muscle cell maintenance and vascular homeostasis in mice: correlates with human disease. Cell Death Differ. 2009, 16:1590-1598.
15. Boettger T., Beetz N., Kostin S., Schneider J., Kruger M., Hein L., Braun T. Acquisition of the contractile phenotype by murine arterial smooth muscle cells depends on the Mir143/145 gene cluster. J. Clin. Invest. 2009, 119:2634-2647.
16. Cordes K.R., Sheehy N.T., White M.P., Berry E.C., Morton S.U., Muth A.N., Lee T.H., Miano J.M., Ivey K.N., Srivastava D. miR-145 and miR-143 regulate smooth muscle cell fate and plasticity. Nature 2009, 460:705-710.
17. Rangrez A.Y., M'Baya-Moutoula E., Metzinger-Le Meuth V., Henaut L., Djelouat M.S., Benchitrit J., Massy Z.A., Metzinger L. Inorganic phosphate accelerates the migration of vascular smooth muscle cells: evidence for the involvement of miR-223. PLoS One 2012, 7:e47807.
18. Urbich C., Kuehbacher A., Dimmeler S. Role of microRNAs in vascular diseases, inflammation, and angiogenesis. Cardiovasc. Res. 2008, 79:581-588.
19. Wu F., Yang Z., Li G. Role of specific microRNAs for endothelial function and angiogenesis. Biochem. Biophys. Res. Commun. 2009, 386:549-553.
20. Liu X., Cheng Y., Zhang S., Lin Y., Yang J., Zhang C. A necessary role of miR-221 and miR-222 in vascular smooth muscle cell proliferation and neointimal hyperplasia. Circ. Res. 2009, 104:476-487.
21. Haneklaus M., Gerlic M., Kurowska-Stolarska M., Rainey A.A., Pich D., McInnes I.B., Hammerschmidt W., O'Neill L.A., Masters S.L. Cutting edge: miR-223 and EBV miR-BART15 regulate the NLRP3 inflammasome and IL-1beta production. J. Immunol. 2011, 189:3795-3799.
22. Greco S., De Simone M., Colussi C., Zaccagnini G., Fasanaro P., Pescatori M., Cardani R., Perbellini R., Isaia E., Sale P., Meola G., Capogrossi M.C., Gaetano C., Martelli F. Common micro-RNA signature in skeletal muscle damage and regeneration induced by Duchenne muscular dystrophy and acute ischemia. FASEB J. 2009, 23:3335-3346.
23. Lu H., Buchan R.J., Cook S.A. MicroRNA-223 regulates Glut4 expression and cardiomyocyte glucose metabolism. Cardiovasc. Res. 2010, 86:410-420.
24. Sugatani T., Hruska K.A. MicroRNA-223 is a key factor in osteoclast differentiation. J. Cell. Biochem. 2007, 101:996-999.
25. Fichtlscherer S., De Rosa S., Fox H., Schwietz T., Fischer A., Liebetrau C., Weber M., Hamm C.W., Roxe T., Muller-Ardogan M., Bonauer A., Zeiher A.M., Dimmeler S. Circulating microRNAs in patients with coronary artery disease. Circ. Res. 2010, 107:677-684.
26. Massy Z.A., Taupin P., Jungers P., Landais P. Prediction model of coronary heart disease in patients with chronic kidney disease: role of plasma fibrinogen as a new prognostic variable. Prilozi 2005, 26:63-77.
27. Abedin M., Tintut Y., Demer L.L. Vascular calcification: mechanisms and clinical ramifications. Arterioscler. Thromb. Vasc. Biol. 2004, 24:1161-1170.
28. Bartel D.P. MicroRNAs: target recognition and regulatory functions. Cell 2009, 136:215-233.
29. Ivanovski O., Nikolov I.G., Joki N., Caudrillier A., Phan O., Mentaverri R., Maizel J., Hamada Y., Nguyen-Khoa T., Fukagawa M., Kamel S., Lacour B., Drueke T.B., Massy Z.A. The calcimimetic R-568 retards uremia-enhanced vascular calcification and atherosclerosis in apolipoprotein E deficient (apoE-/-) mice. Atherosclerosis 2009, 205:55-62.
30. Li J., Guo Y., Liang X., Sun M., Wang G., De W., Wu W. MicroRNA-223 functions as an oncogene in human gastric cancer by targeting FBXW7/hCdc4. J. Cancer Res. Clin. Oncol. 2012, 138:763-774.
31. Suffee N., Richard B., Hlawaty H., Oudar O., Charnaux N., Sutton A. Angiogenic properties of the chemokine RANTES/CCL5. Biochem. Soc. Trans. 2011, 39:1649-1653.
32. D'Apolito M., Du X., Zong H., Catucci A., Maiuri L., Trivisano T., Pettoello-Mantovani M., Campanozzi A., Raia V., Pessin J.E., Brownlee M., Giardino I. Urea-induced ROS generation causes insulin resistance in mice with chronic renal failure. J. Clin. Invest. 2010, 120:203-213.
33. Zorzano A., Palacin M., Guma A. Mechanisms regulating GLUT4 glucose transporter expression and glucose transport in skeletal muscle. Acta Physiol. Scand. 2005, 183:43-58.
34. Zampetaki A., Kiechl S., Drozdov I., Willeit P., Mayr U., Prokopi M., Mayr A., Weger S., Oberhollenzer F., Bonora E., Shah A., Willeit J., Mayr M. Plasma microRNA profiling reveals loss of endothelial miR-126 and other microRNAs in type 2 diabetes. Circ. Res. 2010, 107:810-817.
35. Hunter M.P., Ismail N., Zhang X., Aguda B.D., Lee E.J., Yu L., Xiao T., Schafer J., Lee M.L., Schmittgen T.D., Nana-Sinkam S.P., Jarjoura D., Marsh C.B. Detection of microRNA expression in human peripheral blood microvesicles. PLoS One 2008, 3:e3694.
36. Tuccoli A., Poliseno L., Rainaldi G. miRNAs regulate miRNAs: coordinated transcriptional and post-transcriptional regulation. Cell Cycle 2006, 5:2473-2476.
37. Eiring A.M., Harb J.G., Neviani P., Garton C., Oaks J.J., Spizzo R., Liu S., Schwind S., Santhanam R., Hickey C.J., Becker H., Chandler J.C., Andino R., Cortes J., Hokland P., Huettner C.S., Bhatia R., Roy D.C., Liebhaber S.A., Caligiuri M.A., Marcucci G., Garzon R., Croce C.M., Calin G.A., Perrotti D. miR-328 functions as an RNA decoy to modulate hnRNP E2 regulation of mRNA translation in leukemic blasts. Cell 2010, 140:652-665.
38. Six I., Maizel J., Barreto F.C., Rangrez A.Y., Dupont S., Slama M., Tribouilloy C., Choukroun G., Maziere J.C., Bode-Boeger S., Kielstein J.T., Drueke T.B., Massy Z.A. Effects of phosphate on vascular function under normal conditions and influence of the uraemic state. Cardiovasc. Res. 2013, 96:130-139.
39. Kin K., Miyagawa S., Fukushima S., Shirakawa Y., Torikai K., Shimamura K., Daimon T., Kawahara Y., Kuratani T., Sawa Y. Tissue- and plasma-specific MicroRNA signatures for atherosclerotic abdominal aortic aneurysm. J. Am. Heart Assoc. 2012, 1:e000745.
40. Chen N.X., Kiattisunthorn K., O'Neill K.D., Chen X., Moorthi R.N., Gattone V.H., Allen M.R., Moe S.M. Decreased microRNA is involved in the vascular remodeling abnormalities in chronic kidney disease (CKD). PLoS One 2013, 8:e64558.
41. Saikumar J., Hoffmann D., Kim T.M., Gonzalez V.R., Zhang Q., Goering P.L., Brown R.P., Bijol V., Park P.J., Waikar S.S., Vaidya V.S. Expression, circulation, and excretion profile of microRNA-21, -155, and -18a following acute kidney injury. Toxicol. Sci. 2012, 129:256-267.